Home > Products > HER2 & VEGF
> Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (scIgG)
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (scIgG) (CAT#: SCIGG-168)
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-HER2 and anti-VEGF IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind two factors simultaneously and inhibit cell proliferation. It is designed for the research of Colorectal cancer; Breast cancer; Lung cancer; Renal cell cancer (RCC); Glioma cancer; Glioblastoma; Ovarian cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (scIgG) (SCIGG-168). Click the button below to contact us or submit your feedback about this product.